| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/22/2006 | CN1751025A Diamine derivatives |
| 03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 03/22/2006 | CN1749254A Double spiro material containing heteroaton and its synthetic method and use |
| 03/22/2006 | CN1246432C Ligand and complex for catalytically bleaching substrate |
| 03/22/2006 | CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 03/22/2006 | CN1246039C Moxilfloxacin formulation containing common salt |
| 03/21/2006 | US7015333 Process for preparation of imidazolyl compounds |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | US7014836 Synthesis of ITQ-17 in the absence of fluoride ions |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2186285C Carbonyl containing compounds and their derivatives as multi-functional fuel and lube additives |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006027694A1 Inhibitors of the hiv integrase enzyme |
| 03/16/2006 | WO2006027474A2 Novel imidazopyridine derivatives having an affinity with respect to melatonin receptors, method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 03/16/2006 | WO2006027370A1 PREPARATION OF 9-HYDROXY-3- (2-HYDROXYETHYL) -2-METHYL-4H-PYRID0[1, 2-a] PYRIMIDIN-4-ONE AND CRYSTALS THEREOF |
| 03/16/2006 | WO2006027366A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity |
| 03/16/2006 | WO2006026927A1 A new polymorph of dolasetron mesylate monohydrate and preparation thereof |
| 03/16/2006 | WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/16/2006 | WO2005115399A3 Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands |
| 03/16/2006 | WO2005115361A3 Androgen receptor modulators and method of treating disease using the same |
| 03/16/2006 | WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 03/16/2006 | WO2005103003A3 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
| 03/16/2006 | WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators |
| 03/16/2006 | WO2005077344A3 Hydantoin derivatives as inhibitors of cellular necrosis |
| 03/16/2006 | WO2005063745A3 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 03/16/2006 | WO2005039486A3 Compounds and compositions as protein kinase inhibitors |
| 03/16/2006 | WO2005016884A9 Cyclopropyl derivatives as nk3 receptor antagonists |
| 03/16/2006 | WO2005016235A3 Combined use of impdh inhibitors with toll-like receptor agonists |
| 03/16/2006 | US20060058778 Novel compounds |
| 03/16/2006 | US20060058570 Radioactive member and method of making |
| 03/16/2006 | US20060058528 Processes for preparing quinolone carboxylate derivatives |
| 03/16/2006 | US20060058360 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 03/16/2006 | US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof |
| 03/16/2006 | US20060058342 For therapy and prophylaxis of hypokalemia, hypertension, congestive heart failure, renal failure, in particular, chronic renal failure, restenosis, atherosclerosis, syndrome X, obesity, nephropathy, post-myocardial infarction, coronary heart diseases, increased formation of collagen, fibrosis |
| 03/16/2006 | US20060058339 Compounds modulating c-kit activity and uses therefor |
| 03/16/2006 | US20060058338 [1,7]naphthyridines as pde4 inhibitors |
| 03/16/2006 | US20060058321 Enzyme inhibitors for kinases and antitumor agents with bicyclic or tricyclic compounds with thiophene ring |
| 03/16/2006 | US20060058319 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 03/16/2006 | US20060058316 Side effect reduction; asthma; antiinflammatory agent; cognition enhancers; 2-{3'-[3-[(Cyclopropylamino)carbonyl]-4-oxo-1,8-naphthyridin-1(4H)-yl]-1-biphenyl-4-yl}cyclopropanecarboxylic acid |
| 03/16/2006 | US20060058315 2-Oxo-ethanesulfonamide derivates |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058305 Antiproliferative agents such as 3-(3-trifluoromethylphenyl)cinnolin-5-ol |
| 03/16/2006 | US20060058295 Novel compounds as pharmaceutical agents |
| 03/16/2006 | US20060058284 Compounds such as tert-butyl 3-(3,4-dichlorophenyl)-3-[3-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)propyl]pyrrolidine-1-carboxylate;useful in the inhibition of HIV replication, therapy and prophylaxis of an HIV infection, and in therapy of the resulting acquired immune deficiency syndrome (AIDS) |
| 03/16/2006 | CA2579303A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2579059A1 Chemical compounds |
| 03/16/2006 | CA2578841A1 Inhibitors of the hiv integrase enzyme |
| 03/16/2006 | CA2578741A1 1-alkoxy 1h-imidazo ring systems and methods |
| 03/15/2006 | EP1634927A2 Crystal growth modifiers for perylene pigments |
| 03/15/2006 | EP1634881A1 Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof |
| 03/15/2006 | EP1633751A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 03/15/2006 | EP1633750A2 Synthesis of 5-substituted 7-azaindoles and 7-azaindolines |
| 03/15/2006 | EP1633749A2 Deazaflavin compounds and methods of use thereof |
| 03/15/2006 | EP1633737A1 Quinolyl amide derivatives as ccr-5 antagonists |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633716A2 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |
| 03/15/2006 | EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 03/15/2006 | EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 03/15/2006 | EP1633310A2 Thiotungstate analogues and uses thereof |
| 03/15/2006 | EP1461040B1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1383498B1 Crf receptor antagonists |
| 03/15/2006 | EP1379244A4 1,4,5,6-tetrahydropyrazolo- 3,4-c]-pyridin-7-ones as factor xa inhibitors |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1331937B1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309593B1 Substituted pyrazoles |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1020446B1 Naphthalimidobenzamide derivatives |
| 03/15/2006 | EP0804438B1 Tricyclic benzazepine vasopressin antagonists |
| 03/15/2006 | CN1747953A Aryl / hetaryl substituted imidazoquinolines. |
| 03/15/2006 | CN1747951A Novel 2-pyridinecarboxamide derivatives |
| 03/15/2006 | CN1747949A Acyclic pyrazole compounds |
| 03/15/2006 | CN1746171A Heterocyclic hepyramine derivative, its preparation and use thereof |
| 03/15/2006 | CN1746170A Poly-substituted pyridino-[4,3d] pyramine with antibacterial and herbicide activity and its production thereof |
| 03/15/2006 | CN1245404C Mercaptoacetylamide derivatives, process for their preparation and use thereof |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/14/2006 | US7012144 Bactericides |
| 03/14/2006 | US7012143 Map kinases inhibitors; antiinflammatory agents; osteoporosis; antiarthritic agents; anticancer agents; antiischemic agents; cardiovascular disorders; autoimmune diseases |
| 03/14/2006 | US7012142 Sultam compounds |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | US7012080 Imidazopyridine compounds as 5-HT4 receptor agonists |
| 03/14/2006 | US7012078 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc. |
| 03/14/2006 | US7011916 A photoconductor element comprising a charge generation material and an electron transport agent |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | CA2210631C Tricyclic benzazepine vasopressin antagonists |
| 03/14/2006 | CA2165800C Antiallergic imidazoazepines |
| 03/14/2006 | CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 03/09/2006 | WO2006025567A1 Novel substituted imidazole derivatives |
| 03/09/2006 | WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | WO2006024666A1 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |